Avantor Inc at Morgan Stanley Global Healthcare Conference Transcript
All right. Good morning, everyone, to day 2 of the Morgan Stanley Healthcare Conference. My name is Tejas Savant, and I'm the life science tools and diagnostics analyst here at MS.
It's my pleasure to host Avantor this morning. And on behalf of the company, we have Michael Stubblefield, CEO. Thank you for joining us, Michael.
Before we get started, just some important disclosures, please use the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, do reach out to your sales rep.
Questions & Answers
So Michael, maybe just to kick things off, Avantor has seen its pressure of challenges with the COVID headwinds, the inventory destock, softer demand in pharma, semis, et cetera. But just at this stage, could you talk about how '23 has played out so far versus your initial expectations at the start of the year? And what are you sort of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |